Melasma

Pigmentary ICD: L81.1

Also known as: Chloasma, Mask of Pregnancy

Description

Melasma is an acquired pigmentary disorder characterised by symmetric brown to grey-brown patches on sun-exposed areas of the face. It is particularly common in women of reproductive age and in Fitzpatrick skin types III–V. UV exposure and hormonal factors (pregnancy, oral contraceptives) are key triggers.

Symptoms

  • Symmetric brown or grey-brown macules and patches
  • Most common on cheeks, forehead, upper lip, chin
  • Worsens with sun exposure
  • No associated itching or pain
  • Significant cosmetic and psychosocial impact

Causes & Triggers

  • UV radiation (primary trigger)
  • Hormonal influences (oestrogen, progesterone)
  • Genetic predisposition
  • Visible light and heat exposure
  • Certain medications (phototoxic drugs)

Severity Classification

Epidermal Brown patches — responds better to topical therapy
Dermal Grey-blue patches — deeper pigment, more resistant
Mixed Combination of epidermal and dermal — most common type

Treatment Ladder

  1. 1 Foundational: Strict broad-spectrum sunscreen (SPF 50+) + visible light protection
  2. 2 First-line: Triple combination cream (hydroquinone + tretinoin + steroid)
  3. 3 Alternatives: Azelaic acid 15–20% or tranexamic acid (oral/topical)
  4. 4 Adjuncts: Vitamin C, niacinamide, glycolic acid peels
  5. 5 Refractory: Chemical peels, microneedling, or laser (with caution in darker skin)

Relevant Compounds

Alpha Arbutin

Tyrosinase inhibitor for gradual depigmentation

Alpha arbutin is a biosynthetic glycosylated hydroquinone derivative that inhibits melanin productio…

Azelaic Acid

Tyrosinase inhibitor — depigmenting with anti-inflammatory action

Azelaic acid is a naturally occurring dicarboxylic acid produced by Malassezia furfur. It has antiba…

Coenzyme Q10

Antioxidant — supports cell renewal

Coenzyme Q10 (ubiquinone) is a naturally occurring lipid-soluble benzoquinone that is present in vir…

Glycolic Acid

Superficial peeling agent — enhances penetration of depigmenting agents

Glycolic acid is the smallest alpha hydroxy acid with the greatest bioavailability due to its low mo…

Kojic Acid

Copper chelation to inhibit tyrosinase

Kojic acid is a natural metabolite produced by several species of fungi (Aspergillus, Penicillium). …

Niacinamide

Inhibits melanosome transfer to keratinocytes

Niacinamide is the physiologically active amide form of vitamin B3. It is a versatile, well-tolerate…

Retinol

Milder retinoid for maintenance therapy

Retinol is an over-the-counter retinoid and a precursor to retinoic acid (tretinoin). It must be con…

Tretinoin

Accelerates epidermal turnover and disperses melanin

Tretinoin is a first-generation retinoid derived from vitamin A. It is one of the most extensively s…

Vitamin C

Tyrosinase inhibitor to reduce melanin synthesis

Vitamin C is a potent water-soluble antioxidant essential for collagen synthesis. In topical skincar…

Vitamin E

Antioxidant — photoprotection adjunct

Vitamin E is a fat-soluble antioxidant vitamin and a key component of the skin's natural antioxidant…

Recommended Drugs

Suggested Cosmetics

Lifestyle Tips

  • Sunscreen is THE most important intervention — reapply every 2 hours outdoors
  • Use tinted sunscreen with iron oxides for visible light protection
  • Avoid waxing the face during active treatment
  • Be patient — visible improvement takes 8–12 weeks minimum
  • Hormonal review if linked to oral contraceptives

When to Refer

  • Refractory melasma not responding to 6 months of topical therapy
  • Consideration of procedural interventions (peels, laser)
  • Diagnostic uncertainty (rule out post-inflammatory hyperpigmentation, lichen planus pigmentosus)